Therefore, any treatment that results in a decrease in the level of LEP or hypersensitivity to LEP may be a good strategy to prevent lifestyle diseases, very often associated with obesity [55]. This evidence concerns the gene LEP and obesity due to melanocortin 4 receptor deficiency.